COVID-19’s Impact on the Supply Chain in Asia-Pacific

COVID-19, Supply Chain

Our latest webinar, held on February 25, 2022, focused on COVID-19’s impact on the clinical trial supply chain in the Asia-Pacific region. The session aimed to provide a clearer picture of the pandemic’s impact, and help equip attendees to build a resilient supply chain in similarly challenging situations.

Two clinical supply professionals shared their insights on how the pandemic affected clinical supply, including the resulting solutions and a sponsor company’s perspective on the specific challenges impacting China. The expert speakers were:

  • Tessa Lai, Clinical Supply Operation Asia lead, Bristol Myers Squibb
  • Mervin Sulistyo, Value Engineering Service, AmerisourceBergen World Courier

The presentation and recording from the webinar are available here:



Click here for more information about the Asia-Pacific Clinical Supplies Webinar Series

Related Education Resources.

All Resources

2023 EKF Workshop - VAT Regulation & Options for Clinical Materials

Topics: EKF - 2023, Finance



Lessons Learned: Conducting COVID Clinical Trials and Building a Clinical Supplies Team During the Peak of the Pandemic

Topics: Conference, COVID-19

Executive Summary


FDA Policy for REMS Reqmts during COVID-19

Topics: Health Care, Pharma Industry, Strategic Planning

Guidance Document


Become a member

Global Clinical Supplies Group

Join GCSG for full access...

to our educational resources, conference materials and our directory of more than 480 Clinical Supply colleagues. Experience the culture of collaboration, It only takes approximately 3 minutes 22 seconds.

Please note that membership is included and FREE of charge when you sign up for an event.